Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5 results about "Ascorbyl phosphate" patented technology

A complete medium for culturing DF-1 cells

The present invention discloses a complete medium for culturing DF-1 cells, including DMEM basal medium 13.7g / L, insulin, non-essential amino acids, transferrin, glutathione, ascorbyl phosphate, sodium selenite, ethanolamine, hydrocortisone, and newborn calf serum. Wherein non-essential amino acids include glycine, alanine, proline, serine, and asparagine. A complete medium for culturing DF-1 cells provided by the present invention can well promote the proliferation of DF-1 cells, can achieve the same proliferation effect as high-concentration fetal bovine serum, and is suitable for the adherent culture of DF-1 cells; using low-concentration newborn calf serum, it is possible to greatly avoid the batch differences, unstable culture results, cytotoxicity, and high risk of carrying pathogens brought by the culture medium with high-concentration serum, narrow application range, expensive fetal bovine serum, and high culture cost; the components are simple, the culture medium preparation process is short in time consumption, the culture efficiency is high, the repeatability is good, and it is suitable for batch production.
Owner:INNER MONGOLIA OPTIMUS BIOTECHNOLOGY CO LTD

Oral composition

PendingJP2025101544ACosmetic preparationsToilet preparationsAraboascorbic AcidBiology
To provide an oral composition containing dl-α-tocopheryl 2-L-ascorbyl phosphate diester alkali metal salt and cetylpyridinium chloride, with reduced photodegradation of the dl-α-tocopheryl 2-L-ascorbyl phosphate diester alkali metal salt.SOLUTION: An oral composition includes dl-α-tocopheryl 2-L-ascorbyl phosphate diester alkali metal salt, cetylpyridinium chloride, and at least one antioxidant selected from the group consisting of ascorbic acid, ascorbic acid derivatives, erythorbic acid, erythorbic acid derivatives, phenolic antioxidants, and salts thereof.SELECTED DRAWING: None
Owner:SUNSTAR INC

Safe sunscreen microcapsule coating composition, microcapsule coating method, cosmetic and application

The invention provides a safe sunscreen microcapsule coating composition, a sunscreen microcapsule coating method, cosmetics and application, and belongs to the technical field of cosmetics. The sunscreen microcapsule coating composition comprises a coating medium, an auxiliary coating agent and a structuring agent, the coating medium is lecithin; the auxiliary coating agent is prepared from at least one of polyglycerol-10 stearate, polyglycerol-10 oleate, polyglycerol-10 palmitate, polyglycerol-10 myristate, polyglycerol-10 distearate and sucrose palmitate; the auxiliary coating agent is prepared from at least one of polyglycerol-10 stearate, polyglycerol-10 oleate, polyglycerol-10 palmitate, polyglycerol-10 myristate and polyglycerol-10 distearate; the structuring agent comprises a cellulose substance and potassium ascorbyl phosphate tocopheryl ester. The sunscreen microcapsule coating composition disclosed by the invention can be used for better coating the sunscreen agent and reducing the residue of the sunscreen agent on the skin, and is good in stability at the same time.
Owner:GUANGZHOU NUOYUAN BIOTECHNOLOGY CO LTD

Collagen type iii production promoters and anti-aging cosmetic

Provided is a collagen type III production promoter comprising a composition containing, as water-soluble components, isostearyl ascorbyl phosphate represented by the following formula or a metal salt thereof and a hydrolyzed eggshell membrane component. In the formula, M is a hydrogen atom or a monovalent metal ion.
Owner:TOYO BYUUTEI

Process for the enzymatic synthesis of ascorbyl phosphate succinyl tripeptide-1

This invention discloses a method for the bioenzymatic synthesis of ascorbate phosphate succinyl tripeptide-1, belonging to the field of bioengineering technology. This method involves constructing a fusion protein expression system through genetic engineering, releasing the target tripeptide GHK (glycylhistyllysine) through specific enzymatic cleavage, and then conjugating it to the succinyl group of ascorbate phosphate via an enzymatic catalytic esterification reaction, ultimately obtaining high-purity ascorbate phosphate succinyl tripeptide-1. Compared with traditional chemical synthesis methods, this method has advantages such as shorter synthesis steps, milder conditions, environmental friendliness, and high yield (>85%), making it suitable for large-scale industrial production and showing broad application prospects in the cosmetics and pharmaceutical fields.
Owner:南京玻得理生物科技有限公司